Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection

Nuclear Medicine and Biology

Volumn 31, Issue 5, 2004, Pages 671-677

  Luo, Tsai Yueh ^a,b   Hsieh, Bor Tsung ^c   Wang, Shyh Jen ^d   Lin, Wan Yu ^d   Lee, Te Wei ^a   Shen, Lie Hang ^a   Su, Ming Jai ^b  

^a INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

188Re ECD; Hepatic tumor; Intrahepatic artery; Lipiodol

Indexed keywords

CHELATING AGENT; CHLORINE DERIVATIVE; CYSTEINE ETHYL ESTER TC 99M; EDETIC ACID; IODINATED POPPYSEED OIL; IODINATED POPPYSEED OIL RE 188; RADIOPHARMACEUTICAL AGENT; REDUCING AGENT; TARTARIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BONE; BRAIN; BRAIN PERFUSION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG PURITY; DRUG STABILITY; DRUG SYNTHESIS; HEPATIC ARTERY; ISOTOPE LABELING; LIVER TUMOR; MALE; MUSCLE; NONHUMAN; RADIATION DOSE; RADIOACTIVITY; RADIOCHEMISTRY; RAT; SPLEEN; STOMACH; TESTIS; THYROID GLAND;

ANIMALS; DRUG COMBINATIONS; HEPATIC ARTERY; INJECTIONS, INTRA-ARTERIAL; IODIZED OIL; ISOTOPE LABELING; LIVER; LIVER NEOPLASMS; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; ORGANOMETALLIC COMPOUNDS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 3042574046     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2004.02.005     Document Type: Article

References (34)

1. Kew M.C., Geddes E.W. Hepatocellular carcinoma in rural southern African blacks. Medicine. 61:1982;98-108
2. Okuda K., Thtsuki O., Obata H., Tomimatsu M., Okazaki N., Hasegawa H., Nakajima Y., Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment; study of 850 patients. Cancer. 56:1985;918-928
3. Lin T.Y., Lee C.S., Chen K.M., Chen C.C. Role of surgery in the treatment of primary carcinoma of the liver a 31-year experience. Br J Surg. 74:1987;839-842
4. Chen D.S., Sheu J.C., Sung J.L., Lai M.Y., Lee C.S., Su C.T., Tsang Y.M., How S.W., Wang T.H., Yu J.Y., Yang T.H., Wang C.Y., Hsu C.Y. Small hepatocellular carcinoma a clinic pathological study in thirteen patients. Gastroenterology. 83:1982;1109-1119
5. Park C.H., Suh J.H., Yoo H.S., Lee J.T., Kim D.I. Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma. Clin Nucl Med. 11:1986;514-517
6. Ohishi H., Uchida H., Yoshimura H., Ohue S., Ueda J., Katsuragi M., Matsuo N., Hosogi Y. Hepatocellular carcinoma detected by iodized oil - use of anticancer agents. Radiology. 154:1985;25-29
7. 188Re-TDD, for the treatment of liver cancer. Nucl Med and Biol. 28:2001;197-204
8. Lencieoni R., Vignali C., Caramella D., Cioni R., Mazzeo S., Bartolozzi C. Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma. Cardiovasc Intervent Radiol. 17:1994;70-75
9. Risse J.H., Ponath C., Palmedo H., Menzel C., Grunwald F., Biersack H.J. Radiation exposure and radiation protection of the physician in iodine-131 Lipiodol therapy of liver tumours. Eur J Nucl Med. 28:2001;914-918
10. Wang S.J., Lin W.Y., Chen M.N., Shen L.H., Tsai Z.T., Ting G. Preparation and biodistribution of Yttrium-90 Lipiodol in rats following hepatic arterial injection. Eur J Nucl Med. 22:1995;233-236
11. Wang S.J., Lin W.Y., Lui W.Y., Chen M.N., Tsai Z.T., Ting G. Hepatic artery injection of Yttrium-90-Lipiodol biodistribution in rats with hepatoma. J Nucl Med. 37:1996;332-335
12. Wang S.J., Lin W.Y., Chen M.N., Hsieh B.T., Shen L.H., Tsai Z.T., Ting G., Knapp F.F. Jr. Biodistribution of rhenium-188 Lipiodol infused via the hepatic artery of rats with hepatic tumours. Eur J Nucl Med. 23:1996;13-17
13. Wang S.J., Lin W.Y., Hsieh B.T., Shen L.H., Tsai Z.T., Ting G. Radiolabeling of Lipiodol with generator-produced Rhenium-188 for hepatic tumor therapy. Appl Radiat Isot. 47:1996;267-271
14. 188Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer. Nucl Medi Comm. 23:2002;237-242
15. Sundram F.X., Jeong J.M., Zanzonlco P., Bernal P. Trans-arterial Rhenium-188 Lipiodol in the treatment of inoperable hepatocellular carcinoma. An IAEA sponsored multi-centre phase 1 study. World J Nucl Med. 1:2002;5-11
16. Walovitch R.C., Hill T.C., Garrity S.T., Cheesman E.H., Burgess B.A., O'Leary D.H., Watson A.D., Ganey M.V., Morgan R.A., Williams S.J. Characterization of Technetium-99m-L, L-ECD for brain perfusion imaging, part 1 pharmacology of Technetium-99m ECD in nonhuman primates. J Nucl Med. 30:1989;1892-1901
17. Lin C.P., Hsieh B.T., Ting G., Yeh S.J. Determination of impurities in the eluate of rhenium generator using hydrated magnesium oxide on the preconcentration agent. J Radioanal Nucl Chem. 236:1998;165-168
18. Blondeau P., Berse C., Gravel D. Dimerization of an intermediate during the sodium in liquid ammonium reduction of L-thiazolidine-4-carboxylic acid. Can J Chem. 45:1967;49-59
19. TM, package insert. DuPont Pharmaceuticals Company Medical Imaging, USA
20. Maki S., Konno T., Maeda H. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective targeting with oily contrast medium. Cancer. 56:1985;751-757
21. Konno T., Maeda H., Iwai K., Tashiro S., Maki S., Morinaga T., Mochinaga M., Hiraoka T., Yokoyama I.T. Effects of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma a preliminary report. Eur J Cancer Clin Oncol. 19:1983;1053-1065
22. Nakamura H., Hashimoto T., Oi H., Sawada S. Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology. 170:1989;783-786
23. Kobayashi H., Hidaka Y., Tanque P., Tanoue P., Inoue H., Ikeda K., Nakajo M., Shinohara S.H. Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution. Acta Radiol Diagn. 27:1986;139-147
24. Raoul J.L., Duvauferrier R., Bourguet P. Lipiodolized angiography with I-131-iodine labeled iodized oil in malignant hepatoma. J Radiol. 67:1986;797-801
25. Hsieh B.T., Hsieh J.F., Tsai S.C., Lin W.Y., Huang H.T., Ting G., Wang S.J. Rhenium-188-labeled DTPA a new radiopharmaceutical for intravascular radiation therapy. Nucl Med Biol. 26:1999;967-972
26. Nicolini M., Brandoli G., Mazzi U. Technetium and rhenium in chemistry and nuclear medicine. 1990;Raven Press, New York
27. Holman B.L., Hellman R.S., Goldsmith S.J., Mena I.G., Leveille J., Gherardi P.G., Moretti J.L., Bischof-Delaloye A., Hill T.C., Rigo P.M., et al. Biodistribution, dosimetry, and clinical evaluation of technetium-99m ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction. J Nucl Med. 30:1989;1018-1024
28. Iwai K., Maeda H., Konno T. Use of oily contrast medium for selective drug targeting to tumor enhanced therapeutic effect and X-ray image. Cancer Res. 44:1984;2115-2121
29. Ngan H. Lipiodol computerized tomography how sensitive and specific is the technique in the diagnosis of hepatocellular carcinoma. Br J Radiol. 63:1990;771-775
30. Kobayashi H., Inoue H., Shimada J., Yano T., Maeda T., Oyama T., Shinohara S. Intra-arterial injection of adriamycin /mitomycin C Lipiodol suspension in liver metastases. Acta Radiol. 28:1987;275-280
31. Park C., Choi S.I., Kim H., Yoo H.S., Lee Y.B. Distribution of Lipiodol in hepatocellular carcinoma. Liver. 10:1990;72-78
32. Kan Z., Ivancev K., Hagerstrand I., Chuang V., Lunderquist A. In vivo microscopy of the liver after injection of Lipiodol into the hepatic artery and portal vein in the rat. Acta Radiol. 30:1989;419-425
33. Okuda K., Musha H., Yamasaki T., Musha H., Jinnouchi S. Angiographic demonstration of invasion of hepatocellular carcinoma in the hepatic vein and inferior vena cava. Rinsho Hoshasen (Jap J Clin Radiol). 22:1977;1267-1274
34. Bledin A.G., Kantarjian H.M., Kim E.E. Technetium-99m-labeled macroaggregated albumin in intrahepatic arterial chemotherapy. Am J Roentgen. 139:1982;711-715